190 related articles for article (PubMed ID: 35705526)
21. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract][Full Text] [Related]
22. PKK suppresses tumor growth and is decreased in squamous cell carcinoma of the skin.
Poligone B; Gilmore ES; Alexander CV; Oleksyn D; Gillespie K; Zhao J; Ibrahim SF; Pentland AP; Brown MD; Chen L
J Invest Dermatol; 2015 Mar; 135(3):869-876. PubMed ID: 25285922
[TBL] [Abstract][Full Text] [Related]
23. Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17.
Guinea-Viniegra J; Zenz R; Scheuch H; Jiménez M; Bakiri L; Petzelbauer P; Wagner EF
J Clin Invest; 2012 Aug; 122(8):2898-910. PubMed ID: 22772468
[TBL] [Abstract][Full Text] [Related]
24. L-3-Phosphoserine phosphatase (PSPH) regulates cutaneous squamous cell carcinoma proliferation independent of L-serine biosynthesis.
Bachelor MA; Lu Y; Owens DM
J Dermatol Sci; 2011 Sep; 63(3):164-72. PubMed ID: 21726982
[TBL] [Abstract][Full Text] [Related]
25. Cav1 suppresses tumor growth and metastasis in a murine model of cutaneous SCC through modulation of MAPK/AP-1 activation.
Trimmer C; Bonuccelli G; Katiyar S; Sotgia F; Pestell RG; Lisanti MP; Capozza F
Am J Pathol; 2013 Mar; 182(3):992-1004. PubMed ID: 23267770
[TBL] [Abstract][Full Text] [Related]
26. KLF4 suppresses the tumor activity of cutaneous squamous cell carcinoma (SCC) cells via the regulation of SMAD signaling and SOX2 expression.
Li XM; Kim SJ; Hong DK; Jung KE; Choi CW; Seo YJ; Lee JH; Lee Y; Kim CD
Biochem Biophys Res Commun; 2019 Sep; 516(4):1110-1115. PubMed ID: 31284949
[TBL] [Abstract][Full Text] [Related]
27. ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma.
Luo J; Xia Y; Yin Y; Luo J; Liu M; Zhang H; Zhang C; Zhao Y; Yang L; Kong L
Theranostics; 2019; 9(21):6334-6353. PubMed ID: 31534554
[No Abstract] [Full Text] [Related]
28. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
29. A Novel Germline Deletion of p.C630 in RET Causes MTC and Promotes Cell Proliferation and Sensitivity to Pralsetinib.
Ma X; Ma X; Chin L; Zhu Z; Han H
J Clin Endocrinol Metab; 2022 Aug; 107(9):2636-2643. PubMed ID: 35689816
[TBL] [Abstract][Full Text] [Related]
30. Loss of FAM83H promotes cell migration and invasion in cutaneous squamous cell carcinoma via impaired keratin distribution.
Tokuchi K; Kitamura S; Maeda T; Watanabe M; Hatakeyama S; Kano S; Tanaka S; Ujiie H; Yanagi T
J Dermatol Sci; 2021 Nov; 104(2):112-121. PubMed ID: 34657752
[TBL] [Abstract][Full Text] [Related]
31. Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes.
Mizrahi A; Barzilai A; Gur-Wahnon D; Ben-Dov IZ; Glassberg S; Meningher T; Elharar E; Masalha M; Jacob-Hirsch J; Tabibian-Keissar H; Barshack I; Roszik J; Leibowitz-Amit R; Sidi Y; Avni D
Oncogene; 2018 Jan; 37(2):218-230. PubMed ID: 28925390
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor receptor activation and inhibition in 3D in vitro models of normal skin and human cutaneous squamous cell carcinoma.
Commandeur S; van Drongelen V; de Gruijl FR; El Ghalbzouri A
Cancer Sci; 2012 Dec; 103(12):2120-6. PubMed ID: 22974223
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic Regulation of iASPP-p63 Feedback Loop in Cutaneous Squamous Cell Carcinoma.
Robinson DJ; Patel A; Purdie KJ; Wang J; Rizvi H; Hufbauer M; Ostano P; Akgül B; Chiorino G; Harwood CA; Bergamaschi D
J Invest Dermatol; 2019 Aug; 139(8):1658-1671.e8. PubMed ID: 30710576
[TBL] [Abstract][Full Text] [Related]
34. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
[TBL] [Abstract][Full Text] [Related]
35. T-cadherin loss induces an invasive phenotype in human keratinocytes and squamous cell carcinoma (SCC) cells in vitro and is associated with malignant transformation of cutaneous SCC in vivo.
Pfaff D; Philippova M; Buechner SA; Maslova K; Mathys T; Erne P; Resink TJ
Br J Dermatol; 2010 Aug; 163(2):353-63. PubMed ID: 20394625
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer.
Dazard JE; Gal H; Amariglio N; Rechavi G; Domany E; Givol D
Oncogene; 2003 May; 22(19):2993-3006. PubMed ID: 12771951
[TBL] [Abstract][Full Text] [Related]
37. Pre-mRNA processing factor 3 enhances the progression of keratinocyte-derived cutaneous squamous cell carcinoma by regulating the JAK2/STAT3 pathway.
Zuo S; Li X; Bao W; Li S
Sci Rep; 2020 Jun; 10(1):8863. PubMed ID: 32483193
[TBL] [Abstract][Full Text] [Related]
38. Growth and Viability of Cutaneous Squamous Cell Carcinoma Cell Lines Display Different Sensitivities to Isoform-Specific Phosphoinositide 3-Kinase Inhibitors.
Mannella V; Boehm K; Celik S; Ali T; Mirza AN; El Hasnaouy M; Kaffa A; Lyu Y; Kafaei Golahmadi D; Leigh IM; Bergamaschi D; Harwood CA; Maffucci T
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808215
[TBL] [Abstract][Full Text] [Related]
39. RSPO1-mutated keratinocytes from palmoplantar keratoderma display impaired differentiation, alteration of cell-cell adhesion, EMT-like phenotype and invasiveness properties: implications for squamous cell carcinoma susceptibility in patients with 46XX disorder of sexual development.
Dellambra E; Cordisco S; Delle Monache F; Bondanza S; Teson M; Nicodemi EM; Didona B; Condorelli AG; Camerino G; Castiglia D; Guerra L
Orphanet J Rare Dis; 2022 Jul; 17(1):275. PubMed ID: 35854363
[TBL] [Abstract][Full Text] [Related]
40. Sirolimus diminishes the expression of GRO-α (CXCL-1) /CXCR2 axis in human keratinocytes and cutaneous squamous cell carcinoma cells.
Schaper-Gerhardt K; Hansel A; Walter A; Grimmelmann I; Gutzmer R
J Dermatol Sci; 2021 Oct; 104(1):30-38. PubMed ID: 34479772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
